DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Ausgabe 06 · Volume 38 · 1977 DOI: 10.1055/s-008-39931

Editorial

0391
Walsh, Peter N.: Publication of Symposia in Thrombosis and Haemostasis

Editorial Note

0395
Hawkey, Christine: The Importance of Comparative Studies

Original Article

0399
Walsh, Peter N.; Goldberg, Richard E.; Tax, Richard L.; Magargal, Larry E.: Platelet Coagulant Activities and Retinal Vein Thrombosis
0407
Hegt, Vincent Noordhoek: Relations between Activation and Inhibition of Fibrinolysis in the Walls of Human Arteries and Veins
0420
Moake, J. L; Cimo, P. L; Widmer, K; Peterson, D. M; Gum, J. R: Effects of Prostaglandins, Derivatives of Cyclic 3':5'-AMP, Theophylline, Cholinergic Agents and Colchicine on Clot Retraction in Dilute Platelet-Rich Plasma and Gel-Separated Platelet Test Systems
0429
Murtaugh, Patricia A.: Comparison of the Cross-Linking Patterns of Lamprey Fibrinogen and Fibrin by the Action of the Intrinsic Lamprey Factor XIII and Human Factor XIII during the Process of Blood Coagulation
0438
Walter, M; Nyman, D; Krajnc, V; Duckert, F: The Activation of Plasma Factor XIII with the Snake Venom Enzymes Ancrod and Batroxobin Marajoensis
0447
McMartin, Donald N.: Spontaneous Atrial Thrombosis in Aged Syrian Hamsters
0457
Dodds, W. Jean; Raymond, Sharon L.; Moynihan, Ann C.; McMartin, Donald N.: Spontaneous Atrial Thrombosis in Aged Syrian Hamsters II. Hemostasis
0465
Constantino, M; Merskey, C; Kudzma, D. J; Zucker, M. B: Increased Activity of Vitamin K-Dependent Clotting Factors in Human Hyperlipoproteinaemia – Association with Cholesterol and Triglyceride Levels
0475
Borsodi, Anna D.; Bradshaw, Ralph A.: Isolation of Antithrombin III from Normal and α1-Antitrypsin-Deficient Human Plasma
0486
Marciniak, Ewa: Antithrombin III and Heparin Inactivation in Thrombin Involving Reactions
0494
Pepper, D. S; Banhegyi, D; Cash, J. D: The Different Forms of Antithrombin III in Serum
0504
Preston, F. E; Malia, R. G; Lilleyman, J. S; Blackburn, E. K: Heparinised Clotting Factor Concentrates in Patients with Christmas Disease and Liver Disease
0510
Barbui, Tiziano; Rodeghiero, Francesco; Dini, Enrico: The Aspirin Tolerance Test in von Willebrand’s Disease
0514
Blatt, Philip M.; White, Gilbert C.; McMillan, Campbell W.; Roberts, Harold R.: Treatment of Anti-Factor VIII Antibodies
0524
Alkjaersig, Norma; Davies, Andrew; Fletcher, Anthony: Fibrin and Fibrinogen Proteolysis Products: Comparison between Gel Filtration and SDS Polyacrylamide Electrophoresis Analysis
0536
Andrassy, K; Ritz, E: Preparation (Agar Zone Electrophoresis) and Immunological Characterisation of Urokinase
0545
Marsh, N. A; Gaffney, P. J: The Rapid Fibrin Plate – a Method for Plasminogen Activator Assay
0552
Arkel, Yale S.; Haft, Jacob I.; Kreutner, William; Sherwood, Joseph; Williams, Rae: Alteration in Second Phase Platelet Aggregation Associated with an Emotionally Stressful Activity

International Committee Communications

0562
GAFFNEY, PATRICK J: Report of the Task Force on Standards for Thrombin and Thrombin-Like Enzymes
0567
JACKSON, CRAIG M: Recommended Nomenclature for Blood Clotting Zymogens and Zymogen Activation Products of the International Committee on Thrombosis and Hemostasis

Letters to the Editor

0578
Beck, Eugene A: Effects of Heparin on Platelet Reactivity in Citrated Plasma
0581
Farina, Maria Luisa; Langer, Martin; Donati, Maria Benedetta; de Gaetano, Giovanni: Antiplatelet Treatment in Septic Shock with Severe Bleeding and Thrombocytopenia
0584
Sherman, Laurence A: Disseminated Intravascular Coagulation
0586
Caen, J. P; Michel, H; Sultan, Y; Tobelem, G; Nurden, A. T; Levy-Toledano, S: Comparison of von Willebrand Disease and Bernard-Soulier Syndrome
0588
Loeliger, E. A: Thromboplastin Calibration
0590
Tschopp, Th. B; Muggli, R; Kuhn, H; Baumgartner, H. R: Animal Surgery without Anaesthesia? A Request for Editorial Guidelines
0591
Ahlqvist, Johan: Another Pathologist’s Views on DIC and Thrombosis and on their Relationship to the ESR
0593
Remuzzi, G; Misiani, R; Livio, M; dall’Olio, A; Donati, M. B; de Gaetano, G: Possible Role of HLA-B8 Antigen as a Genetic Marker of Autoimmune Thrombocytopenia in a Patient with Myasthenia Gravis